Published in J Comp Neurol on October 15, 2013
Disruption of Endocytosis with the Dynamin Mutant shibirets1 Suppresses Seizures in Drosophila. Genetics (2015) 0.82
Drosophila sodium channel mutations: Contributions to seizure-susceptibility. Exp Neurol (2015) 0.76
Seizure Suppression by High Temperature via cAMP Modulation in Drosophila. G3 (Bethesda) (2016) 0.75
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (1993) 58.26
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet (2001) 5.61
Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci (2006) 5.02
Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet (1995) 2.25
Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med (2009) 2.20
The Kennedy pathway--De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life (2010) 2.03
A phospholipid acts as a chaperone in assembly of a membrane transport protein. J Biol Chem (1996) 1.89
The Drosophila easily shocked gene: a mutation in a phospholipid synthetic pathway causes seizure, neuronal failure, and paralysis. Cell (1994) 1.85
Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae. Mol Biol Cell (2001) 1.68
Modifications of seizure susceptibility in Drosophila. J Neurophysiol (2000) 1.50
The Drosophila slamdance gene: a mutation in an aminopeptidase can cause seizure, paralysis and neuronal failure. Genetics (2002) 1.36
Genetic suppression of seizure susceptibility in Drosophila. J Neurophysiol (2001) 1.31
Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci (1992) 1.30
Drosophila as a model for epilepsy: bss is a gain-of-function mutation in the para sodium channel gene that leads to seizures. Genetics (2010) 1.23
Phospholipid-assisted refolding of an integral membrane protein. Minimum structural features for phosphatidylethanolamine to act as a molecular chaperone. J Biol Chem (1999) 1.20
Phospholipid membrane composition affects EGF receptor and Notch signaling through effects on endocytosis during Drosophila development. Dev Cell (2003) 1.13
Neural membrane phospholipids in Alzheimer disease. Neurochem Res (1995) 1.09
Neuropathology in Drosophila mutants with increased seizure susceptibility. Genetics (2008) 1.03
A knock-in model of human epilepsy in Drosophila reveals a novel cellular mechanism associated with heat-induced seizure. J Neurosci (2012) 1.01
The CDP-ethanolamine pathway and phosphatidylserine decarboxylation generate different phosphatidylethanolamine molecular species. J Biol Chem (2007) 0.99
Seizure and epilepsy: studies of seizure disorders in Drosophila. Int Rev Neurobiol (2011) 0.99
Lipid composition of subcellular membranes from larvae and prepupae of Drosophila melanogaster. Lipids (1992) 0.99
DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy. Neuroscience (2008) 0.95
Seizure suppression by shakB2, a gap junction mutation in Drosophila. J Neurophysiol (2005) 0.95
Ethanolamine kinase controls neuroblast divisions in Drosophila mushroom bodies. Dev Biol (2005) 0.89
Genetic modifications of seizure susceptibility and expression by altered excitability in Drosophila Na(+) and K(+) channel mutants. J Neurophysiol (2006) 0.88
Structural mass spectrometry analysis of lipid changes in a Drosophila epilepsy model brain. Mol Biosyst (2010) 0.85
Autistic disorder and phospholipids: A review. Prostaglandins Leukot Essent Fatty Acids (2011) 0.83
Gene targets related to phospholipid and fatty acid metabolism in schizophrenia and other psychiatric disorders: an update. Prostaglandins Leukot Essent Fatty Acids (2000) 0.82
Genome-wide analysis of the odorant-binding protein gene family in Drosophila melanogaster. Genome Res (2002) 2.23
Making an escape: development and function of the Drosophila giant fibre system. Semin Cell Dev Biol (2005) 1.77
From bench to drug: human seizure modeling using Drosophila. Prog Neurobiol (2007) 1.24
Drosophila as a model for epilepsy: bss is a gain-of-function mutation in the para sodium channel gene that leads to seizures. Genetics (2010) 1.23
Mutations in the K+/Cl- cotransporter gene kazachoc (kcc) increase seizure susceptibility in Drosophila. J Neurosci (2006) 1.20
Potassium bromide, an anticonvulsant, is effective at alleviating seizures in the Drosophila bang-sensitive mutant bang senseless. Brain Res (2004) 1.06
The mei-P26 gene encodes a RING finger B-box coiled-coil-NHL protein that regulates seizure susceptibility in Drosophilia. Genetics (2005) 1.02
Drosophila couch potato mutants exhibit complex neurological abnormalities including epilepsy phenotypes. Genetics (2005) 1.01
Seizure and epilepsy: studies of seizure disorders in Drosophila. Int Rev Neurobiol (2011) 0.99
Seizure suppression by gain-of-function escargot mutations. Genetics (2005) 0.96
Seizure suppression by shakB2, a gap junction mutation in Drosophila. J Neurophysiol (2005) 0.95
Seizure sensitivity is ameliorated by targeted expression of K+-Cl- cotransporter function in the mushroom body of the Drosophila brain. Genetics (2009) 0.88
Drosophila as a model for intractable epilepsy: gilgamesh suppresses seizures in para(bss1) heterozygote flies. G3 (Bethesda) (2013) 0.85
Seizure-sensitivity in Drosophila is ameliorated by dorsal vessel injection of the antiepileptic drug valproate. J Neurogenet (2013) 0.83
Neurocircuit assays for seizures in epilepsy mutants of Drosophila. J Vis Exp (2009) 0.80